At Genomics England, our vision is a world where everyone benefits from genomic healthcare.
From the latest research to the lived experiences of those affected by rare conditions and cancer, Behind the Genes brings you closer to the people behind the science.
Each month, we release a deep-dive episode, alongside our Genomics 101 series - short explainers designed to make complex terms in genetics and genomics easier to understand.
Episodes
Thursday Oct 07, 2021
Thursday Oct 07, 2021
“We have a wild card here that is changing the risk-benefit equation for all babies in order to detect these rare cases.”
In this week’s episode, our Chief Executive Officer, Chris Wigley, is joined by Dr Robert Green, Professor of Medicine (Genetics) at Harvard Medical School and a physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Additionally, Dr Green is principal investigator of the NIH-funded REVEAL Study and is internationally recognised for research and policy efforts accelerating the implementation of genomic/precision medicine.
Today Robert talks about his work around newborn sequencing with The BabySeq Project and what the programme is hoping to achieve. He also discusses Genomes2People and the research they conduct to accelerate the implementation of genomic medicine and the promise of precision health.
No comments yet. Be the first to say something!